CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 120 enrolled
Drug / intervention
Biohorizons Laser-lok bonelevel dental implantsdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02661243
NCT02661243N/ACompleted
CompareCT.gov

Implantology and Sjögren's Syndrome: a Multicenter Prospective Cohort Study

Derk Jan Jager·interventional·Posted Jan 22, 2016·Updated Apr 30, 2019

In Brief

A clinical study evaluating Biohorizons Laser-lok bonelevel dental implants for Sjogren's Syndrome. Completed, enrolled 120 participants across 5 sites.

Detailed Summary

Until now it has not been investigated whether placement of implants in SS patients is less successful than compared to non-SS patients. The risk factors and the efficacy of dental implants in dry mouth patients are not known because of the lack of scientific evidence. The aim of this study is to investigate changes in marginal peri-implant bone loss and the clinical performance of dental implants in SS patients compared to implants in healthy patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSjogren's Syndrome
CountriesNetherlands
CollaboratorsUMC Utrecht, University Medical Center Groningen, Tandartspraktijk Bocht Oosterdiep, Isala, BioHorizons, Inc., Fonds NutsOhra

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 22, 2016
Enrollment StartMay 1, 2015
Primary CompletionFeb 1, 2019
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 10.4 years ago

Interventions

Biohorizons Laser-lok bonelevel dental implantsdevice

Insertion of Biohorizons Laser-lok bonelevel dental implants to replace missing (pre)molars or to stabilize a denture